FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progr... | RTCL.TV
Channel: Social RTCL TV
Date: 18/10/2023

### Keywords ###
#experiencingstable #experiencingprogressive #combinationtherapy #stabledisease #progressivedisease #studyfound #patientsexperienced #RTCLTV #shorts

### Article Attribution ###
Title: FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Authors: Giuseppe Procopio, Prabhu Bhagavatheeswaran, Bernard Escudier, Chung-Han Lee, Shruti Shally Saggi, Suresh Nair, Ruth Perets, Michael A Carducci, Vincent Castonguay, Edmund Folefac, Sebastien J. Hotte, Wilson H Miller, ,and Heshani Desilva
Publisher: BMJ Publishing Group
DOI: 10.1136/jitc-2022-005780
DOAJ URL: https://doaj.org/article/b2458af932914c44a5e2518aa22ce139
Source URL: https://jitc.bmj.com/content/10/11/e005780.full



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@socialrtcltv
Odysee Channel: https://odysee.com/@social_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:34 - Title 
0:00:41 - End